Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of telepsychiatry during the COVID-19 pandemic across service users, carers and clinicians: an international mixed-methods study.
Sheriff R, Hong JSW, Henshall C, D'Agostino A, Tomassi S, Stein HC, Cerveri G, Cibra C, Bonora S, Giordano B, Smith T, Phiri P, Asher C, Elliot K, Zangani C, Ede R, Saad F, Smith KA, Cipriani A. Sheriff R, et al. Among authors: asher c. BMJ Ment Health. 2023 Aug;26(1):e300646. doi: 10.1136/bmjment-2022-300646. BMJ Ment Health. 2023. PMID: 37567731 Free PMC article.
Results of a prospective, mixed methods study to assess feasibility, acceptability and effectiveness of TRIumPH (Treatment and Recovery In PsycHosis): an integrated care pathway for psychosis, compared to usual treatment.
Rathod S, Thorne K, Graves E, Phiri P, Asher C, Griffiths A, Read T, Kingdon D. Rathod S, et al. Among authors: asher c. BMJ Open. 2020 Apr 29;10(4):e033711. doi: 10.1136/bmjopen-2019-033711. BMJ Open. 2020. PMID: 32354777 Free PMC article.
Protocol for a multicentre study to assess feasibility, acceptability, effectiveness and direct costs of TRIumPH (Treatment and Recovery In PsycHosis): integrated care pathway for psychosis.
Rathod S, Garner C, Griffiths A, Dimitrov BD, Newman-Taylor K, Woodfine C, Hansen L, Tabraham P, Ward K, Asher C, Phiri P, Naeem F, North P, Munshi T, Kingdon D. Rathod S, et al. Among authors: asher c. BMJ Open. 2016 Dec 21;6(12):e012751. doi: 10.1136/bmjopen-2016-012751. BMJ Open. 2016. PMID: 28003288 Free PMC article.
The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomized, double-blind, placebo-controlled trial.
Whicher CA, Price HC, Phiri P, Rathod S, Barnard-Kelly K, Ngianga K, Thorne K, Asher C, Peveler RC, McCarthy J, Holt RIG. Whicher CA, et al. Among authors: asher c. Diabetes Obes Metab. 2021 Jun;23(6):1262-1271. doi: 10.1111/dom.14334. Epub 2021 Feb 16. Diabetes Obes Metab. 2021. PMID: 33528914 Clinical Trial.
212 results